The integrated model is notable because it places addiction care within routine internal medicine training rather than in a separate specialty setting. That structure may help normalize SUD treatment alongside diabetes, hypertension, and other chronic disease management. It may also reduce logistical and stigma-related barriers for patients who might not seek care at a specialty addiction center.
The medication focus is clinically relevant. Buprenorphine, a partial μ-opioid receptor agonist, is an evidence-based medication for OUD and can reduce illicit opioid use and overdose risk when incorporated into longitudinal care.4 Other medications used in addiction treatment include methadone and extended-release naltrexone for OUD, as well as naltrexone, acamprosate, and disulfiram for AUD. Broader recommendations also support identifying unhealthy drug use in adults when diagnosis, treatment, or referral services are available.5
For residency programs, the Cincinnati experience suggests that hands-on exposure may be more effective than didactic teaching alone for building clinical readiness. The outcome measured, however, was confidence rather than independent competency or patient-centered outcomes. The evaluation was also small, single center, and short term, with paired survey data from 11 residents. The summary did not report quantitative changes in medication initiation rates, treatment retention, substance use outcomes, overdose events, or longer-term practice patterns after graduation.
Ellen Jochum, chief physician resident who practiced in the clinic, said the experience helped translate classroom learning into outpatient primary care. “I feel much more prepared because of my experiences and now feel comfortable starting treatment for patients with a substance use disorder, knowing resources available to them,” she said in the press release.2
Next steps identified by the research team include assessing whether this type of rotation affects patient outcomes over time and whether residents continue providing addiction treatment after training. For other academic medical centers, the study offers an implementation example, but replication will require attention to faculty expertise, pharmacy support, workflow design, and sustained access to community recovery resources.
References
- Binder M, Brizzi MB, Santen SA. Chan CA. Development of an addiction medicine clinic integrated into an internal medicine ambulatory practice. Acad Med. Published online May 5, 2026. doi:10.1093/acamed/wvaf097
- University of Cincinnati. Study finds integrating substance use disorder treatment into clinic-based internal medicine expands access to care. News release. May 18, 2026. Accessed May 19, 2026. https://www.uc.edu/news/articles/2026/05/uc-primary-care-clinic-substance-use-disorder-training.html
- Substance Abuse and Mental Health Services Administration. 2024 National Survey on Drug Use and Health. SAMHSA; 2025. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health/national-releases/2024#annual-national-report
- National Academies of Sciences, Engineering, and Medicine. Medications for Opioid Use Disorder Save Lives. National Academies Press; 2019.
- US Preventive Services Task Force; Krist AH, Davidson KW, et al. Screening for unhealthy drug use: US Preventive Services Task Force recommendation statement. JAMA. 2020;323(22):2301-2309. doi:10.1001/jama.2020.8020